The University of Southampton
University of Southampton Institutional Repository

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome
Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome
The shift to a genotype-first approach in genetic diagnostics has revolutionized our understanding of neurodevelopmental disorders, expanding both their molecular and phenotypic spectra. Kleefstra syndrome (KLEFS1) is caused by EHMT1 haploinsufficiency and exhibits broad clinical manifestations. EHMT1 encodes euchromatic histone methyltransferase-1—a pivotal component of the epigenetic machinery. We have recruited 209 individuals with a rare EHMT1 variant and performed comprehensive molecular in silico and in vitro testing alongside DNA methylation (DNAm) signature analysis for the identified variants. We (re)classified the variants as likely pathogenic/pathogenic (molecularly confirming Kleefstra syndrome) in 191 individuals. We provide an updated and broader clinical and molecular spectrum of Kleefstra syndrome, including individuals with normal intelligence and familial occurrence. Analysis of the EHMT1 variants reveals a broad range of molecular effects and their associated phenotypes, including distinct genotype-phenotype associations. Notably, we showed that disruption of the “reader” function of the ankyrin repeat domain by a protein altering variant (PAV) results in a KLEFS1-specific DNAm signature and milder phenotype, while disruption of only “writer” methyltransferase activity of the SET domain does not result in KLEFS1 DNAm signature or typical KLEFS1 phenotype. Similarly, N-terminal truncating variants result in a mild phenotype without the DNAm signature. We demonstrate how comprehensive variant analysis can provide insights into pathogenesis of the disorder and DNAm signature. In summary, this study presents a comprehensive overview of KLEFS1 and EHMT1, revealing its broader spectrum and deepening our understanding of its molecular mechanisms, thereby informing accurate variant interpretation, counseling, and clinical management.
DNA methylation, EHMT1, H3K9, Kleefstra syndrome, NDD, neurodevelopmental disorders
0002-9297
1605-1625
Rots, Dmitrijs
995e212f-8c65-49b3-b0bc-43e130dc251e
Bouman, Arianne
6f4a064f-a9a6-456c-a915-ff295d721cb6
Yamada, Ayumi
1967725a-edf0-41d6-a747-7d8a3b388343
Levy, Michael
94554776-8835-49a8-a812-5cff00c061f9
Dingemans, Alexander J.M.
8aaa3be3-ff3a-4796-ad61-a633a8cdc98f
de Vries, Bert B.A.
6db437b1-2e03-42c3-9551-9636a6857896
Ruiterkamp-Versteeg, Martina
4ba37dff-0a09-4ee4-af5f-e1ebe8e76c38
de Leeuw, Nicole
813aec91-d6e5-43c9-9e40-081f958cab10
Ockeloen, Charlotte W.
52f37389-4c55-4a28-b7ec-f903f93f2f7a
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Foulds, Nicola
5e153e9f-caae-45f5-b6f0-943bd567558e
Pfundt, Rolph
0c14b79d-29d2-4d86-a82a-2636cfa5bb24
et al.
Rots, Dmitrijs
995e212f-8c65-49b3-b0bc-43e130dc251e
Bouman, Arianne
6f4a064f-a9a6-456c-a915-ff295d721cb6
Yamada, Ayumi
1967725a-edf0-41d6-a747-7d8a3b388343
Levy, Michael
94554776-8835-49a8-a812-5cff00c061f9
Dingemans, Alexander J.M.
8aaa3be3-ff3a-4796-ad61-a633a8cdc98f
de Vries, Bert B.A.
6db437b1-2e03-42c3-9551-9636a6857896
Ruiterkamp-Versteeg, Martina
4ba37dff-0a09-4ee4-af5f-e1ebe8e76c38
de Leeuw, Nicole
813aec91-d6e5-43c9-9e40-081f958cab10
Ockeloen, Charlotte W.
52f37389-4c55-4a28-b7ec-f903f93f2f7a
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Foulds, Nicola
5e153e9f-caae-45f5-b6f0-943bd567558e
Pfundt, Rolph
0c14b79d-29d2-4d86-a82a-2636cfa5bb24

Rots, Dmitrijs, Bouman, Arianne and Yamada, Ayumi , et al. (2024) Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome. The American Journal of Human Genetics, 111 (8), 1605-1625. (doi:10.1016/j.ajhg.2024.06.008).

Record type: Article

Abstract

The shift to a genotype-first approach in genetic diagnostics has revolutionized our understanding of neurodevelopmental disorders, expanding both their molecular and phenotypic spectra. Kleefstra syndrome (KLEFS1) is caused by EHMT1 haploinsufficiency and exhibits broad clinical manifestations. EHMT1 encodes euchromatic histone methyltransferase-1—a pivotal component of the epigenetic machinery. We have recruited 209 individuals with a rare EHMT1 variant and performed comprehensive molecular in silico and in vitro testing alongside DNA methylation (DNAm) signature analysis for the identified variants. We (re)classified the variants as likely pathogenic/pathogenic (molecularly confirming Kleefstra syndrome) in 191 individuals. We provide an updated and broader clinical and molecular spectrum of Kleefstra syndrome, including individuals with normal intelligence and familial occurrence. Analysis of the EHMT1 variants reveals a broad range of molecular effects and their associated phenotypes, including distinct genotype-phenotype associations. Notably, we showed that disruption of the “reader” function of the ankyrin repeat domain by a protein altering variant (PAV) results in a KLEFS1-specific DNAm signature and milder phenotype, while disruption of only “writer” methyltransferase activity of the SET domain does not result in KLEFS1 DNAm signature or typical KLEFS1 phenotype. Similarly, N-terminal truncating variants result in a mild phenotype without the DNAm signature. We demonstrate how comprehensive variant analysis can provide insights into pathogenesis of the disorder and DNAm signature. In summary, this study presents a comprehensive overview of KLEFS1 and EHMT1, revealing its broader spectrum and deepening our understanding of its molecular mechanisms, thereby informing accurate variant interpretation, counseling, and clinical management.

Text
EHMT1 - Version of Record
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 18 June 2024
e-pub ahead of print date: 15 July 2024
Published date: 8 August 2024
Keywords: DNA methylation, EHMT1, H3K9, Kleefstra syndrome, NDD, neurodevelopmental disorders

Identifiers

Local EPrints ID: 509215
URI: http://eprints.soton.ac.uk/id/eprint/509215
ISSN: 0002-9297
PURE UUID: c58b4754-23c7-4ed8-9b5d-e862af1f4a16
ORCID for Diana Baralle: ORCID iD orcid.org/0000-0003-3217-4833

Catalogue record

Date deposited: 13 Feb 2026 17:34
Last modified: 14 Feb 2026 02:43

Export record

Altmetrics

Contributors

Author: Dmitrijs Rots
Author: Arianne Bouman
Author: Ayumi Yamada
Author: Michael Levy
Author: Alexander J.M. Dingemans
Author: Bert B.A. de Vries
Author: Martina Ruiterkamp-Versteeg
Author: Nicole de Leeuw
Author: Charlotte W. Ockeloen
Author: Diana Baralle ORCID iD
Author: Nicola Foulds
Author: Rolph Pfundt
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×